Amble vs Hims
Recorded prices, access and terms.
Decision table
The entries below are recorded provider statements unless a regulatory source is linked. A provider webpage does not independently verify its licenses or quality. Amble source · Hims source.
| Compare | Amble | Hims |
|---|---|---|
| Recorded medication/program subtotal | Recorded medication and program subtotal — semaglutide: $179/month. Other required fees, labs, dose changes and renewal terms: unconfirmed. This is not a verified all-in treatment cost. | Monthly-plan rate unconfirmed. Advertised headline prices may require prepayment, a specific dose or introductory terms. Full required cost is unconfirmed. |
| Full required monthly cost | Unconfirmed: consultation, labs, membership, dose changes and shipping must be checked | Unconfirmed: consultation, labs, membership, dose changes and shipping must be checked |
| Drug type listed | Compounded | Brand-name |
| Consultation | Included in the record; current conditions unconfirmed | $0 in the record; current conditions unconfirmed |
| Pharmacy license | Not independently verified. Obtain the dispensing pharmacy name and verify its state license. | Not independently verified. Obtain the dispensing pharmacy name and verify its state license. |
| Reported states | 50; confirm eligibility and clinician licensing in your state | 45; confirm eligibility and clinician licensing in your state |
| Cancellation | Commitment/restrictions reported; request the current cancellation and refund terms | Cancellation reported; notice, minimum term and refund conditions unconfirmed |
| Clinician/support as reported | Unnamed licensed physicians via async review, 24/7 messaging and scheduled check-ins | Licensed healthcare providers via online consultation |
| Recorded provider check | 2026-09-07 | No date recorded |
Which should you choose?
Ask each provider for the full cost at your prescribed dose, required labs and visits, the dispensing pharmacy, the clinician's state license, renewal charges and written refund terms. Compare those answers with your clinician.
Compounded drugs are not FDA-approved and do not undergo FDA review for safety, effectiveness or quality before marketing. FDA source and recommendations.
Amble: evidence and terms
Hims: evidence and terms
Recorded FDA letter (2025-09-09): FDA reviewed hims.com in August 2025 and found its claims for compounded semaglutide false or misleading, making the products misbranded under FD&C Act sections 502(a) and 502(bb). A matching letter went to the Hers brand the same day. Hims has since removed compounded products from its site. FDA letter.
Compare the full provider directory · Compare recorded price subtotals